Determining threshold values for success after surgical treatment of lumbar spondylodiscitis using quality of life scores.


Journal

Acta orthopaedica et traumatologica turcica
ISSN: 2589-1294
Titre abrégé: Acta Orthop Traumatol Turc
Pays: Turkey
ID NLM: 9424806

Informations de publication

Date de publication:
May 2023
Historique:
medline: 21 7 2023
pubmed: 3 7 2023
entrez: 3 7 2023
Statut: ppublish

Résumé

This study aimed to determine threshold values of validated quality of life (QoL) scores, including Oswestry Disability Index (ODI) and Core Outcome Measures Index (COMI), for predicting a successful outcome following surgical treatment of lumbar spondylodiscitis (LS). Patients with lumbar spondylodiscitis (LS) undergoing surgery in a tertiary referral hospital were included prospectively from 2008-2019. Data were collected both before surgery (T0) and one year after surgery (T1). QoL was measured using ODI and COMI. The successful clinical outcome was defined by the combination of the following four criteria: no recurrence of spondylodiscitis, back pain ≤4 on visual analogue scale or relief of ≥3 points, absence of LS-related neurological deficit, and radiological fusion of the affected segment. For subgroup analysis, group 1 consisted of patients with a favorable treatment outcome (meeting all four criteria), while group 2 included patients with unfavorable treatment outcome (meeting ≤3 criteria). Ninety-two LS patients (median age = 66 years; age range = 57-74) were analyzed. QoL scores improved significantly. Threshold values for the ODI and COMI were calculated at 35 and 4.2 points, respectively. The area under curve for the ODI was 0.856 (95%-CI 0.767- 0.945; P<0.001) and 0.839 (95% CI-0.749-0.928; P<0.001) for the COMI score. Eighty percent of patients achieved a favorable outcome. Objective measurement and evaluation of successful surgical treatment of spondylodiscitis require defined thresholds of quality of life scores. We were able to define such thresholds for Oswestry Disability Index and Core Outcome Measures Index. These can be useful to assess clinically relevant changes and therefore allow a more precise estimation of the post-surgical outcome. Level II, Prognostic study.

Identifiants

pubmed: 37395356
doi: 10.5152/j.aott.2023.22137
pmc: PMC10543916
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

99-103

Références

Eur Spine J. 2016 Apr;25(4):983-99
pubmed: 26585975
Spine (Phila Pa 1976). 2000 Jun 1;25(11):1437-46
pubmed: 10828927
Spine (Phila Pa 1976). 2000 Nov 15;25(22):2940-52; discussion 2952
pubmed: 11074683
J Infect. 2008 Aug;57(2):128-31
pubmed: 18562009
BMC Musculoskelet Disord. 2013 Apr 26;14:148
pubmed: 23622053
Diagn Microbiol Infect Dis. 2019 May;94(1):66-72
pubmed: 30594411
Spine (Phila Pa 1976). 2008 Apr 15;33(8):E246-53
pubmed: 18404094
Spine (Phila Pa 1976). 2016 Feb;41(4):E197-204
pubmed: 26555842
Br Med Bull. 2016 Mar;117(1):121-38
pubmed: 26872859
Arch Orthop Trauma Surg. 2023 May;143(5):2317-2324
pubmed: 35359162
Lancet. 2015 Mar 7;385(9971):875-82
pubmed: 25468170
Eur Spine J. 2018 Jun;27(Suppl 2):229-236
pubmed: 29667140
Spine (Phila Pa 1976). 2000 Dec 15;25(24):3100-3
pubmed: 11124724
Dtsch Arztebl Int. 2008 Mar;105(10):181-7
pubmed: 19629222
Clin Infect Dis. 2002 May 15;34(10):1342-50
pubmed: 11981730
Eur Spine J. 2021 Jun;30(6):1721-1731
pubmed: 32613398
J Orthop Surg (Hong Kong). 2017 May-Aug;25(2):2309499017716068
pubmed: 28639530
Medicine (Baltimore). 2017 May;96(21):e6387
pubmed: 28538361
Dtsch Arztebl Int. 2017 Dec 25;114(51-52):875-882
pubmed: 29321098
World Neurosurg. 2018 Dec;120:e297-e303
pubmed: 30144603
Eur Spine J. 2012 Jan;21(1):122-9
pubmed: 21823035
Eur Spine J. 2012 Aug;21(8):1596-602
pubmed: 22298236
Infect Dis (Lond). 2017 Feb;49(2):95-103
pubmed: 27636869
Clin Infect Dis. 2016 May 15;62(10):1262-1269
pubmed: 26917813
Paraplegia. 1969 Nov;7(3):179-92
pubmed: 5360915
J Clin Epidemiol. 2000 May;53(5):459-68
pubmed: 10812317
Semin Arthritis Rheum. 2009 Aug;39(1):10-7
pubmed: 18550153

Auteurs

Ayla Yagdiran (A)

Department of Orthopedic and Trauma Surgery, University of Cologne, Faculty of Medicine and University Hospital Cologne, Germany.

Krishnan Sircar (K)

Department of Orthopedic and Trauma Surgery, University of Cologne, Faculty of Medicine and University Hospital Cologne, Germany.

Norma Jung (N)

Department I of Internal Medicine, University of Cologne, Faculty of Medicine and University Hospital Cologne, Division of Infectious Diseases, Cologne, Germany.

Peer Eysel (P)

Department of Orthopedic and Trauma Surgery, University of Cologne, Faculty of Medicine and University Hospital Cologne, Germany.

Jan Bredow (J)

Department of Orthopedic and Trauma Surgery, Krankenhaus Porz am Rhein, Cologne, Germany.

Frank Beyer (F)

Department of Orthopedic and Trauma Surgery, Krankenhaus Porz am Rhein, Cologne, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH